Skip to main content
. 2016 Apr 5;11(5):3546–3550. doi: 10.3892/ol.2016.4409

Figure 2.

Figure 2.

Hepatic computed tomography scans. Absence of hepatic metastasis prior to erlotinib treatment was observed on a (A) plain, (B) venous phase and (C) arterial phase scan (arrows). Presence of hepatic metastasis following 8 weeks of erlotinib treatment was observed on a (D) plain, (E) venous phase and (F) arterial phase scan (arrows).